Fluticasone Propionate Powder, Metered
Product Images NDC 85766-237

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 85766-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasone Propionate Diskus Spl Graphic 01)

Chemical structure diagram of fluticasone propionate, the active ingredient in FLUTICASONE PROPIONATE DISKUS. The structure shows the detailed arrangement of atoms and bonds in the molecule.*

FDA Label Image

Figure 1 (Fluticasone Propionate Diskus Spl Graphic 02)

Line graph showing percent change from baseline in FEV1 over 12 weeks for Fluticasone Propionate DISKUS 100 mcg twice daily compared with placebo. The graph plots time in weeks on the x-axis and percent change from baseline in FEV1 on the y-axis, with data points illustrating higher improvement for fluticasone propionate versus placebo throughout the study period.*

FDA Label Image

Figure 2 (Fluticasone Propionate Diskus Spl Graphic 03)

A line graph showing the percent change from baseline in FEV1 over 12 weeks comparing Fluticasone Propionate DISKUS 100 mcg twice daily and placebo. The graph plots weeks on the horizontal axis and percent change on the vertical axis, indicating greater improvement with Fluticasone Propionate DISKUS versus placebo over time.*

FDA Label Image

Figure 3 (Fluticasone Propionate Diskus Spl Graphic 04)

Line graph comparing the percent change from baseline in FEV1 over 12 weeks between Fluticasone Propionate DISKUS 250 mcg twice daily and placebo. The graph shows weeks on the x-axis and percent change on the y-axis, illustrating sustained improvement with Fluticasone Propionate compared to placebo.*

FDA Label Image

Figure 4 (Fluticasone Propionate Diskus Spl Graphic 05)

Line graph depicting percentage change from baseline in FEV1 over 12 weeks for Fluticasone Propionate DISKUS 500 mcg twice daily compared to Placebo. The graph shows weeks on the x-axis and percent change on the y-axis, illustrating superior improvement with Fluticasone versus Placebo at various time points.*

FDA Label Image

Figure A (Fluticasone Propionate Diskus Spl Graphic 06)

An illustration of the FLUTICASONE PROPIONATE DISKUS 100 mcg inhalation powder device showing its labeled parts including the outer case, mouthpiece, lever, thumb grip, and dose counter. The device contains 60 blisters and is designed for respiratory (inhalation) use.*

FDA Label Image

Figure B (Fluticasone Propionate Diskus Spl Graphic 07)

An instructional illustration showing hands holding a FLUTICASONE PROPIONATE DISKUS inhaler device. The image demonstrates the motion of sliding the lever to prepare the dose for inhalation, indicated by a white arrow pointing to the right. The device is orange with a circular label on top.*

FDA Label Image

Figure C (Fluticasone Propionate Diskus Spl Graphic 08)

An instructional illustration showing two hands holding a fluticasone propionate Diskus inhaler. A white arrow indicates the direction to open or operate the device for respiratory inhalation of the powdered medication.*

FDA Label Image

Figure D (Fluticasone Propionate Diskus Spl Graphic 09)

An instructional illustration showing a woman using a red inhaler device, likely a dry powder inhaler, holding it near her mouth as if preparing to inhale the medication.*

FDA Label Image

Figure E (Fluticasone Propionate Diskus Spl Graphic 10)

Illustration showing a woman using a respiratory inhaler device, holding it near her mouth and inhaling. The image demonstrates the proper technique for inhalation of a powdered medication via a diskus device.*

FDA Label Image

Figure F (Fluticasone Propionate Diskus Spl Graphic 11)

An instructional illustration showing hands holding a Diskus inhaler device with an arrow pointing left, likely demonstrating how to operate or open the FLUTICASONE PROPIONATE DISKUS powder inhaler.*

FDA Label Image

Figure G (Fluticasone Propionate Diskus Spl Graphic 12)

An instructional illustration showing a woman rinsing her mouth with water over a sink. A cup of water is on the counter beside her. This image likely demonstrates oral hygiene following use of a respiratory inhalation product.*

FDA Label Image

Figure H (Fluticasone Propionate Diskus Spl Graphic 13)

FLUTICASONE PROPIONATE DISKUS 100 mcg powder inhaler device in red plastic housing. The round label shows the proprietary name, dosage strength 100 mcg, and quantity of 60 blisters. Instructions to note the date opened and use by are partially visible. The product is by Sportpharm LLC.*

FDA Label Image

100 (Label 100mcg)

Packaging label for FLUTICASONE PROPIONATE DISKUS Inhalation Powder 100 mcg by Sportpharm LLC. The label includes NDC 85766-236-01, quantity of 100, manufacturer Prasco Laboratories, and barcode with QR code. Additional lot and batch number placeholders are visible with storage instructions and prescription drug status noted.*

FDA Label Image

250 (Label 250mcg)

Label for FLUTICASONE PROPIONATE DISKUS inhalation powder, 100 mcg strength, metered powder dosage form, labeled for Sportpharm LLC. The label indicates a quantity of 250 doses and includes manufacturing details and drug status as prescription only (RX).*

FDA Label Image

50 (Label 50mcg)

Label for FLUTICASONE PROPIONATE DISKUS Inhalation Powder 50 mcg, metered powder for respiratory inhalation. The label shows Sportpharm LLC as the labeler and indicates a package quantity of 50. It includes the NDC number 85768-235-50 and mentions the product is manufactured for Prasco Laboratories. Additional information about packaging and storage is provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.